Techno Medica Co., Ltd. (JP:6678) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Techno Medica Co., Ltd. reported a strong financial performance for the quarter ending June 30, 2024, with net sales up by 12.9% and operating profit surging by 207.2% from the previous year. The company’s total assets decreased slightly from the previous quarter, while maintaining a high equity-to-asset ratio of 84.4%. Despite the robust results, Techno Medica did not prepare supplementary material or hold a financial results briefing, and kept the cash dividend forecast unchanged.
For further insights into JP:6678 stock, check out TipRanks’ Stock Analysis page.